Literature DB >> 23559575

Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases.

Andreas P Diamantopoulos1, Gulen Hatemi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23559575     DOI: 10.1093/rheumatology/ket130

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  13 in total

Review 1.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

Review 2.  IL-6 blockade in the management of non-infectious uveitis.

Authors:  Giuseppe Lopalco; Claudia Fabiani; Jurgen Sota; Orso Maria Lucherini; Gian Marco Tosi; Bruno Frediani; Florenzo Iannone; Mauro Galeazzi; Rossella Franceschini; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2017-05-20       Impact factor: 2.980

Review 3.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 4.  Pathogenesis of Behçet's disease: autoinflammatory features and beyond.

Authors:  Ahmet Gül
Journal:  Semin Immunopathol       Date:  2015-06-12       Impact factor: 9.623

5.  Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab.

Authors:  Luca Cantarini; Giuseppe Lopalco; Antonio Vitale; Laura Coladonato; Donato Rigante; Orso Maria Lucherini; Giovanni Lapadula; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2014-04-15       Impact factor: 2.980

Review 6.  Update on the treatment of Behçet's syndrome.

Authors:  Sinem Nihal Esatoglu; Gulen Hatemi
Journal:  Intern Emerg Med       Date:  2019-01-25       Impact factor: 3.397

Review 7.  Biological treatments in Behçet's disease: beyond anti-TNF therapy.

Authors:  Francesco Caso; Luisa Costa; Donato Rigante; Orso Maria Lucherini; Paolo Caso; Vittoria Bascherini; Bruno Frediani; Rolando Cimaz; Edoardo Marrani; Laura Nieves-Martín; Mariangela Atteno; Carmela G L Raffaele; Giusyda Tarantino; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2014-06-30       Impact factor: 4.711

Review 8.  Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future.

Authors:  Fahd Adeeb; Austin G Stack; Alexander D Fraser
Journal:  Int J Rheumatol       Date:  2017-09-10

9.  Short-term efficacy of abatacept in the treatment of refractory ocular and cutaneous Behçet's disease.

Authors:  Marcus de Luca Maciel; Marcelo Novello; Fabricio Souza Neves
Journal:  Rheumatol Adv Pract       Date:  2017-07-11

Review 10.  Behçet's disease in children, an overview.

Authors:  Isabelle Koné-Paut
Journal:  Pediatr Rheumatol Online J       Date:  2016-02-18       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.